Total medical devices industry M&A deals worth $4.1bn were announced in North America in August 2021, led by Trulli Bidco’s $2.5bn acquisition of Smiths Medical, according to GlobalData’s deals database.
Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 153.7% over the previous month of $1.62bn and a drop of 29.6% when compared with the last 12-month average of $5.84bn.
North America held a 91.95% share of the global medical devices industry M&A deal value that totalled $4.47bn in August 2021. With a 91.95% share and deals worth $4.11bn, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of M&A deal activity, North America recorded 20 deals during August 2021, marking a decrease of 9.09% over the previous month and a drop of 9.09% over the 12-month average. The US recorded 18 deals during the month.
North America medical devices industry M&A deals in August 2021: Top deals
The top five medical devices industry M&A deals accounted for 99.1% of the overall value during August 2021.
The combined value of the top five medical devices deals stood at $4.07bn, against the overall value of $4.1bn recorded for the month.
The top five medical devices industry M&A deals of August 2021 tracked by GlobalData were:
1) Trulli Bidco $2.5bn acquisition deal with Smiths Medical
2) The $1.1bn acquisition of Intersect ENT by Medtronic
3) Abcam $340m acquisition deal with BioVision
4) The $100m acquisition of Genuity Science by Hibercell
5) Nano-X Imaging $30m acquisition deal with USARAD Holdings